Probiotic strain Lactobacillus casei BL23 prevents colitis-associated colorectal cancer

Frontiers in Immunology

Volumn 8, Issue NOV, 2017, Pages

  Jacouton, Elsa ^a   Chain, Florian ^a   Sokol, Harry ^a,b   Langella, Philippe ^a   Bermúdez Humarán, Luis G ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

Azoxymethane dextran sodium sulfate; Colorectal cancer; Immunomodulation; Lactic acid bacteria; Lactobacillus casei BL23; Probiotic

Indexed keywords

CASPASE 7; CASPASE 9; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLITIS; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA EXTRACTION; ENTERITIS; GENE AMPLIFICATION; GENE EXPRESSION; INTESTINE FLORA; LACTOBACILLUS CASEI; MICROBIAL DIVERSITY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 85034651295     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01553     Document Type: Article

References (34)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2015) 136:E359-86. doi:10.1002/ijc.29210
2. Muller MF, Ibrahim AE, Arends MJ. Molecular pathological classification of colorectal cancer. Virchows Arch (2016) 469:125-34. doi:10.1007/s00428-016-1956-3
3. Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol (2014) 20:6055-72. doi:10.3748/wjg.v20.i20.6055
4. Izano M, Wei EK, Tai C, Swede H, Gregorich S, Harris TB, et al. Chronic inflammation and risk of colorectal and other obesity-related cancers: the health, aging and body composition study. Int J Cancer (2016) 138:1118-28. doi:10.1002/ijc.29868
5. Mattar MC, Lough D, Pishvaian MJ, Charabaty A. Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res (2011) 4:53-61
6. Food and Agriculture Organization of the United Nations. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London: Food and Agriculture Organization (2002). 11 p
7. Malhotra SL. Dietary factors in a study of cancer colon from Cancer Registry, with special reference to the role of saliva, milk and fermented milk products and vegetable fibre. Med Hypotheses (1977) 3:122-6. doi:10.1016/0306-9877(77)90024-X
8. Young TB, Wolf DA. Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int J Cancer (1988) 42:167-75. doi:10.1002/ijc.2910420205
9. Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control (1992) 3:457-73. doi:10.1007/BF00051359
10. Kampman E, Goldbohm RA, Van Den Brandt PA, Van T Veer P. Fermented dairy products, calcium, and colorectal cancer in The Netherlands Cohort Study. Cancer Res (1994) 54:3186-90
11. Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol (2014) 20:7878-86. doi:10.3748/wjg.v20.i24.7878
12. Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Hontecillas R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One (2012) 7:e34676. doi:10.1371/journal.pone.0034676
13. Foo NP, Yang HO, Chiu HH, Chan HY, Liao CC, Yu CK, et al. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem (2011) 59:13337-45. doi:10.1021/jf203444d
14. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis (2001) 22:599-605. doi:10.1093/carcin/22.4.599
15. Takagi A, Ikemura H, Matsuzaki T, Sato M, Nomoto K, Morotomi M, et al. Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse. J Gastroenterol (2008) 43:661-9. doi:10.1007/s00535-008-2212-7
16. He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci (2017) 7:54. doi:10.1186/s13578-017-0183-1
17. Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One (2009) 4:e6026. doi:10.1371/journal.pone.0006026
18. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 6:e16393. doi:10.1371/journal.pone.0016393
19. Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R, Boleij A, et al. Towards the human colorectal cancer microbiome. PLoS One (2011) 6:e20447. doi:10.1371/journal.pone.0020447
20. Gao ZG, Guo BM, Gao RY, Zhu QC, Qin HL. Microbiota dysbiosis is associated with colorectal cancer. Front Microbiol (2015) 6:20. doi:10.3389/fmicb.2015.00020
21. Zhan Y, Chen PJ, Sadler WD, Wang FY, Poe S, Nunez G, et al. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res (2013) 73:7199-210. doi:10.1158/0008-5472.CAN-13-0827
22. Rochat T, Bermudez-Humaran L, Gratadoux JJ, Fourage C, Hoebler C, Corthier G, et al. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact (2007) 6:22. doi:10.1186/1475-2859-6-22
23. Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefevre F, et al. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol (2010) 144:35-41. doi:10.1016/j.ijfoodmicro.2010.03.037
24. Leblanc JG, Del Carmen S, Miyoshi A, Azevedo V, Sesma F, Langella P, et al. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice. J Biotechnol (2011) 151:287-93. doi:10.1016/j.jbiotec.2010.11.008
25. Lenoir M, Del Carmen S, Cortes-Perez NG, Lozano-Ojalvo D, Munoz-Provencio D, Chain F, et al. Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol (2016) 51(9):862-73. doi:10.1007/s00535-015-1158-9
26. Acedo-Felix E, Perez-Martinez G. Significant differences between Lactobacillus casei subsp casei ATCC 393(T) and a commonly used plasmid-cured derivative revealed by a polyphasic study. Int J Syst Evol Microbiol (2003) 53:67-75. doi:10.1099/ijs.0.02325-0
27. Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med (2016) 22:598. doi:10.1038/nm.4102
28. Perusina Lanfranca M, Lin Y, Fang J, Zou W, Frankel T. Biological and pathological activities of interleukin-22. J Mol Med (Berl) (2016) 94:523-34. doi:10.1007/s00109-016-1391-6
29. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci (2003) 94:965-73. doi:10.1111/j.1349-7006.2003.tb01386.x
30. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, et al. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci (2004) 5:41-8
31. Kumar A, Singh NK, Sinha PR. Inhibition of 1,2-dimethylhydrazine induced colon genotoxicity in rats by the administration of probiotic curd. Mol Biol Rep (2010) 37:1373-6. doi:10.1007/s11033-009-9519-1
32. Kumar A, Singh NK, Sinha PR, Kumar R. Intervention of Acidophilus-casei dahi and wheat bran against molecular alteration in colon carcinogenesis. Mol Biol Rep (2010) 37:621-7. doi:10.1007/s11033-009-9649-5
33. Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature (2012) 491:259-63. doi:10.1038/nature11535
34. Gao C, Ganesh BP, Shi Z, Shah RR, Fultz R, Major A, et al. Gut microbe-mediated suppression of inflammation-associated colon carcinogenesis by luminal histamine production. Am J Pathol (2017) 187:2323-36. doi:10.1016/j.ajpath.2017.06.011